Supplementary Data from Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window

Key points are not available for this paper at this time.

Supplementary Methods and Results

Bookmark

View Full Paper

Cite This Study

Satomaa et al. (Thu,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper